Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $21.0000 (-3.45%) ($21.0000 - $21.0000) on Mon. Aug. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.43% (three month average) | RSI | 48 | Latest Price | $21.0000(-3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.8% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) XBI(41%) IWO(40%) ARKG(39%) IWC(39%) | Factors Impacting IOVA price | IOVA will decline at least -3.215% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-6%) UNG(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.215% (StdDev 6.43%) | Hourly BBV | -1.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $15.9(-24.29%) | Resistance Level | $22.79 | 5 Day Moving Average | $22.19(-5.36%) | 10 Day Moving Average | $22.76(-7.73%) | 20 Day Moving Average | $22.79(-7.85%) | To recent high | -22.7% | To recent low | 30% | Market Cap | $3.075b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |